- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 225/08 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with two six-membered rings
Patent holdings for IPC class C07D 225/08
Total number of patents in this class: 50
10-year publication summary
5
|
2
|
5
|
3
|
3
|
1
|
2
|
5
|
5
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
SynAffix B.V. | 107 |
6 |
Araris Biotech Ltd | 9 |
6 |
University of Georgia Research Foundation, Inc. | 1027 |
5 |
Bristol-myers Squibb Company | 4898 |
2 |
F. Hoffmann-La Roche AG | 7925 |
2 |
Roche Diagnostics Operations, Inc. | 1487 |
2 |
Life Technologies Corporation | 3298 |
2 |
Cancer Targeted Technology LLC | 28 |
2 |
University of Connecticut | 845 |
2 |
Roche Diagnostics GmbH | 2689 |
1 |
Ajinomoto Co., Inc. | 2295 |
1 |
ACADIA Pharmaceuticals Inc. | 205 |
1 |
Emory University | 1626 |
1 |
EnVivo Pharmaceuticals, Inc. | 28 |
1 |
Gracel Display Inc. | 22 |
1 |
Hanmi Pharm. Co., Ltd. | 570 |
1 |
MethylGene Inc. | 41 |
1 |
Peking University | 1308 |
1 |
Purdue Pharma L.P. | 499 |
1 |
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 172 |
1 |
Other owners | 10 |